| 68.705 0.745 (1.1%) | 10-15 14:14 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 82.36 |
1-year : | 96.2 |
| Resists | First : | 70.51 |
Second : | 82.36 |
| Pivot price | 68.77 |
|||
| Supports | First : | 68.06 |
Second : | 66.54 |
| MAs | MA(5) : | 67.89 |
MA(20) : | 68.54 |
| MA(100) : | 66.42 |
MA(250) : | 65.03 |
|
| MACD | MACD : | -0.1 |
Signal : | 0.1  |
| %K %D | K(14,3) : | 30.2 |
D(3) : | 25.9 |
| RSI | RSI(14): 51.9 |
|||
| 52-week | High : | 71.36 | Low : | 56.68 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ VTR ] has closed above bottom band by 46.7%. Bollinger Bands are 12.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 68.22 - 68.7 | 68.7 - 69.07 |
| Low: | 66.45 - 66.97 | 66.97 - 67.37 |
| Close: | 67.29 - 68.08 | 68.08 - 68.7 |
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Tue, 14 Oct 2025
Ventas (VTR): Assessing Valuation After Recent Gains and Modest Pullback - simplywall.st
Sat, 11 Oct 2025
4 Reasons To Buy Ventas And Take Advantage Of Future Return (NYSE:VTR) - Seeking Alpha
Mon, 06 Oct 2025
Ventas Announces Third Quarter 2025 Earnings Release Date and Conference Call - Business Wire
Fri, 03 Oct 2025
What Ventas (VTR)'s Latest Dividend Declaration Reveals About Its Commitment to Shareholder Returns - simplywall.st
Wed, 01 Oct 2025
UBS Initiates Coverage on Ventas (VTR) Citing SHOP Strength and AFFO Growth - Yahoo Finance
Sun, 28 Sep 2025
TD Private Client Wealth LLC Boosts Stake in Ventas, Inc. $VTR - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Real Estate
|
|
|
Industry:
REIT - Healthcare Facilities
|
|
| Shares Out | 454 (M) |
| Shares Float | 452 (M) |
| Held by Insiders | 0.5 (%) |
| Held by Institutions | 101.6 (%) |
| Shares Short | 10,050 (K) |
| Shares Short P.Month | 15,500 (K) |
| EPS | 0.43 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 25.39 |
| Profit Margin | 3.6 % |
| Operating Margin | 16.3 % |
| Return on Assets (ttm) | 2 % |
| Return on Equity (ttm) | 1.8 % |
| Qtrly Rev. Growth | 18.3 % |
| Gross Profit (p.s.) | 4.86 |
| Sales Per Share | 11.61 |
| EBITDA (p.s.) | 4.44 |
| Qtrly Earnings Growth | 215.8 % |
| Operating Cash Flow | 1,520 (M) |
| Levered Free Cash Flow | 1,140 (M) |
| PE Ratio | 159.67 |
| PEG Ratio | 0 |
| Price to Book value | 2.7 |
| Price to Sales | 5.9 |
| Price to Cash Flow | 20.52 |
| Dividend | 0.47 |
| Forward Dividend | 0 |
| Dividend Yield | 0.6% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|